Michael Davis
Lawyers
Filters
European Biotech Acquisition $200 million combination with Oculis
We are advising European Biotech Acquisition Corp. on its deSPAC transaction
Pon sale of interest in Hiller to Littlejohn & Co.
We advised Pon on the transaction
Crestview Partners strategic investment in Digicomm International
We advised Crestview Partners on the transaction
Ygrene Energy Series C funding
We advised Lightyear Capital on the transaction
Bain Capital and ADIA acquisition of Merchants Fleet
We are advising Bain Capital and the consortium on the transaction
Pon sale of its flow control businesses to MiddleGround Capital
We advised Pon on the transaction
Baker Hughes sale of Nexus Controls to GE Gas Power
We are advising Baker Hughes on the transaction
BlockFi $400 million revolving loan facility and FTX option to acquire BlockFi
We advised BlockFi on the transactions
Cerity Partners recapitalization led by Genstar Capital
We are advising Cerity Partners and Lightyear Capital on the transaction
Charles River Laboratories $295 million acquisition of Explora BioLabs Holdings
We advised Charles River on the transaction